Experimental Study on Hepatic-protective Effect of Qinggan Lishi Jiejiu Decoction in Rats with Alcoholic Fatty Liver
|更新时间:2024-01-04
|
Experimental Study on Hepatic-protective Effect of Qinggan Lishi Jiejiu Decoction in Rats with Alcoholic Fatty Liver
Chinese Journal of Experimental Traditional Medical FormulaeVol. 19, Issue 4, Pages: 163-167(2013)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2013
稿件说明:
移动端阅览
LIANG Wei, WU Cheng-yu, LIANG Tao. Experimental Study on Hepatic-protective Effect of Qinggan Lishi Jiejiu Decoction in Rats with Alcoholic Fatty Liver[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(4): 163-167.
DOI:
LIANG Wei, WU Cheng-yu, LIANG Tao. Experimental Study on Hepatic-protective Effect of Qinggan Lishi Jiejiu Decoction in Rats with Alcoholic Fatty Liver[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(4): 163-167.DOI:
Experimental Study on Hepatic-protective Effect of Qinggan Lishi Jiejiu Decoction in Rats with Alcoholic Fatty Liver
Objective: To investigate the prevention and treatment effects of Qinggan Lishi Jiejiu decoction on rats with alcoholic fatty liver(AFL). Method: Male SD rats were randomly divided into 2 groups:normal group and model group. Rats were administered with alcohol and fed with high fat diet including FeSO4 to replicate AFL model. All model rats were divided into model group
the compound Yiganling group (0.042 g·kg-1
) and the Qinggan Lishi Jiejiu decoction group (10
20
40 g·kg-1). While molding
the normal group and the model group were administered saline
the other groups were given corresponding medicine by gavage for 6 weeks. After giving medicine for 6 weeks
we measured the following indexes:weight; liver index; levels of triglyceride(TG)
total cholesterol(TC)
low-density lipoprotein cholesterol(LDL-C)
high-density lipoprotein cholesterol(HDL-C)
aspartate aminotransferase (AST)
alanine aminotransferase(ALT)
glutamyltranspeptidase(GGT) in serum; malondial dehyde(MDA)
superoxide dismutase(SOD) in serum and hepatic tissue. Result: Compared with the model group
in the Qinggan Lishi Jiejiu decoction middle dose group and high dose group
the following indexes were significantly decreased:liver index were (3.18±0.42)
(3.13±0.38)%
the contents of TG were (1.09±0.20)
(1.04±0.14)mmol·L-1
the contents of TC were (1.54±0.14)
(1.51±0.21)mmol·L-1
the contents of LDL-C were (0.15±0.02)
(0.14±0.01)mmol·L-1
the contents of AST were (194.10±16.43)
(171.50±11.40)U·L-1
the contents of ALT were (57.70±5.62)
(50.80±3.52)U·L-1
the contents of GGT were (2.80±0.40)
(1.80±0.40) U·L-1 in serum
the contents of MDA were (6.50±1.32)
(4.70±1.05)μmol·L-1 in serum and (3.07±0.72)
(2.07±0.65)nmol·mg-1 in hepatic tissue; the following indexes were significantly increased:body weights were (316.47±29.47)
(320.71±32.04)g
the contents of HDL-C were (0.55±0.07)
(0.56±0.07)mmol·L-1 in serum
the contents of SOD were (43.67±2.38)
(48.00±1.56)U·mg-1 in serum and (57.31±3.12)
(60.67±1.97)U·mL-1 in hepatic tissue. All the experimental data had statistieal significance(P<0.05
P<0.01). Conclusion: Qinggan Lishi Jiejiu decoction can significantly improve liver function
Effect of the Extract of on the Blood Lipid and Liver Function in Experimental Hyperlipidemia Rats
Clinical Observation of Ganhuangcao Compound Treating Patients with Alcoholic Fatty Liver Disease
Mechanism of Ruyan Neixiao Cream in Promoting Ferroptosis in Breast Precancerous Lesion Cells by Regulating Nrf2/SLC7A11/GPX4 Signaling Pathway
Evaluation of GRADE Clinical Research Evidence of Chinese Patent Medicine Combined with Western Medicine in Treatment of Hypertension with Dyslipidemia
Brusatol Suppresses Proliferation of Human Gastric Cancer HGC-27 Cells Through Inducing Ferroptosis via Nrf2/HO-1 Pathway
Related Author
CHEN Chao-yong
YAN Zhi-yong
LI Shao-hua
CHEN Chong
ZUO Chang-ying
WANG Jin-bo
LI Zheng
ZHAO Yuan-hong
Related Institution
The First Affiliated Hospital, Jinan University
School of Traditional Chinese Medicine, Jinan University
Dongzhimen Hospital, Beijing University of Chinese Medicine
Shaanxi University of Chinese Medicine
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences